ITMI921601A1 - Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. - Google Patents

Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Info

Publication number
ITMI921601A1
ITMI921601A1 IT001601A ITMI921601A ITMI921601A1 IT MI921601 A1 ITMI921601 A1 IT MI921601A1 IT 001601 A IT001601 A IT 001601A IT MI921601 A ITMI921601 A IT MI921601A IT MI921601 A1 ITMI921601 A1 IT MI921601A1
Authority
IT
Italy
Prior art keywords
derivatives
pct
homo
bile acids
absorption promoters
Prior art date
Application number
IT001601A
Other languages
English (en)
Inventor
Giancarlo Ceschel
Aldo Roda
Enrico Roda
Celestino Ronchi
Original Assignee
Monteres S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monteres S R L filed Critical Monteres S R L
Publication of ITMI921601A0 publication Critical patent/ITMI921601A0/it
Priority to ITMI921601A priority Critical patent/IT1255449B/it
Priority to EP93912975A priority patent/EP0652773B1/en
Priority to US08/360,833 priority patent/US5656277A/en
Priority to DE69316217T priority patent/DE69316217T2/de
Priority to JP6501998A priority patent/JPH07508013A/ja
Priority to ES93912975T priority patent/ES2114056T3/es
Priority to DK93912975T priority patent/DK0652773T3/da
Priority to AT93912975T priority patent/ATE161731T1/de
Priority to PCT/EP1993/001508 priority patent/WO1994000155A1/en
Publication of ITMI921601A1 publication Critical patent/ITMI921601A1/it
Application granted granted Critical
Publication of IT1255449B publication Critical patent/IT1255449B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITMI921601A 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. IT1255449B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
JP6501998A JPH07508013A (ja) 1992-06-30 1993-06-15 医薬物用吸収促進剤としてのノルおよびホモ胆汁酸誘導体の使用
US08/360,833 US5656277A (en) 1992-06-30 1993-06-15 Nor- and homo- bile acids derivatives as absorption enhancers for medicaments
DE69316217T DE69316217T2 (de) 1992-06-30 1993-06-15 Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
EP93912975A EP0652773B1 (en) 1992-06-30 1993-06-15 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments
ES93912975T ES2114056T3 (es) 1992-06-30 1993-06-15 Uso de derivados nor y homo de acidos biliares como potenciadores de absorcion para medicamentos.
DK93912975T DK0652773T3 (da) 1992-06-30 1993-06-15 Anvendelse af nor- og homo-galdesyrederivater somabsorptionsfremmende bestanddele i lægemidler
AT93912975T ATE161731T1 (de) 1992-06-30 1993-06-15 Anwendung von nor- und homo-gallensäurederivaten als absorptienförderer für arzneimittel
PCT/EP1993/001508 WO1994000155A1 (en) 1992-06-30 1993-06-15 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Publications (3)

Publication Number Publication Date
ITMI921601A0 ITMI921601A0 (it) 1992-06-30
ITMI921601A1 true ITMI921601A1 (it) 1993-12-30
IT1255449B IT1255449B (it) 1995-10-31

Family

ID=11363597

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921601A IT1255449B (it) 1992-06-30 1992-06-30 Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.

Country Status (9)

Country Link
US (1) US5656277A (it)
EP (1) EP0652773B1 (it)
JP (1) JPH07508013A (it)
AT (1) ATE161731T1 (it)
DE (1) DE69316217T2 (it)
DK (1) DK0652773T3 (it)
ES (1) ES2114056T3 (it)
IT (1) IT1255449B (it)
WO (1) WO1994000155A1 (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821970A1 (en) * 1996-08-02 1998-02-04 Edward Henri Charles Verhaeren Carrier composition for influencing the tight junction permeability
DE69834038D1 (de) 1997-07-01 2006-05-18 Isis Pharmaceutical Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
AU759016B2 (en) 1998-10-05 2003-04-03 Penn State Research Foundation, The Compositions and methods for enhancing receptor-mediated cellular internalization
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20030118547A1 (en) * 2000-01-27 2003-06-26 Vandenberg Grant William Composition for intestinal delivery
JP4452970B2 (ja) * 2002-03-27 2010-04-21 日本臓器製薬株式会社 ジクロフェナクナトリウム経口製剤
US7674778B2 (en) 2004-04-30 2010-03-09 Alnylam Pharmaceuticals Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
HUE025409T2 (en) 2005-05-12 2016-02-29 Medizinische Universität Graz Application of 24-norUDCA
SI2182954T1 (sl) * 2007-07-25 2019-04-30 Medizinische Universitat Graz Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
SG11201703717SA (en) 2014-11-06 2017-06-29 Enanta Pharm Inc Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
EP3223823A4 (en) * 2014-11-26 2018-10-17 Enanta Pharmaceuticals, Inc. Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
US11578097B2 (en) 2014-11-26 2023-02-14 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
EP3256134A4 (en) 2015-02-11 2018-10-03 Enanta Pharmaceuticals, Inc. Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
WO2016161003A1 (en) 2015-03-31 2016-10-06 Enanta Phamraceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
WO2017147174A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
US10323060B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
WO2017147159A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
CN110121347A (zh) 2016-11-29 2019-08-13 英安塔制药有限公司 制备磺酰脲胆汁酸衍生物的方法
US10472386B2 (en) 2017-02-14 2019-11-12 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR agonists and methods of use thereof
BR112019020780A2 (pt) 2017-04-07 2020-04-28 Enanta Pharm Inc processo para preparação de derivados de ácido biliar de carbamato de sulfonila
AU2019308326B2 (en) 2018-07-20 2025-07-31 Lipocine Inc. Liver disease
GB201911821D0 (en) 2019-08-16 2019-10-02 Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid Compounds for use in the treatment of liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
IT1212835B (it) * 1983-08-18 1989-11-30 Lehner Ag Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Also Published As

Publication number Publication date
DK0652773T3 (da) 1998-09-07
ES2114056T3 (es) 1998-05-16
DE69316217D1 (de) 1998-02-12
US5656277A (en) 1997-08-12
ITMI921601A0 (it) 1992-06-30
EP0652773B1 (en) 1998-01-07
DE69316217T2 (de) 1998-08-20
EP0652773A1 (en) 1995-05-17
IT1255449B (it) 1995-10-31
ATE161731T1 (de) 1998-01-15
WO1994000155A1 (en) 1994-01-06
JPH07508013A (ja) 1995-09-07

Similar Documents

Publication Publication Date Title
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
DE69530081D1 (de) Gastrin- und cck-antagonisten
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
ES2114931T3 (es) Nuevos esteres esteroidales.
SE9101709L (sv) Lipidderivat som diagnostikum eller kontrastmedel
DE69830504D1 (de) Antithrombotische mitteln
MX9307779A (es) Compuestos benzoicos fundidos.
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
ES2193154T3 (es) Procedimiento para la preparacion de 9-desoxotaxanos.
DE69225410D1 (de) Herstellung von n-acetylneuraminsäure-derivaten
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
FI944169A0 (fi) Menetelmä beta-fenyyli-isoseriinin ja sen analogien valmistamiseksi
DE69834271D1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
DK0649405T3 (da) 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler.
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
FI932388A0 (fi) 8-en-19,11b-bryggsteroider, deras framstaellning och farmaceutiska preparat innehaollande dem
DK0609336T3 (da) Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ
IT1264765B1 (it) Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960627